Lawsuits filed in federal court by individuals who allege that they suffered a femur fracture after taking a both Fosamax and Boniva, Fosamax and Reclast, or all three bisphosphonate drugs,…
A panel of drug experts convened by the FDA has stopped short of calling for a specific time limit on the use of Fosamax and other bone-strengthening drugs, instead recommending…
Some oral osteoporosis drugs, known as bisphosponates, may increase the risk of esophageal cancer, according to a statement issued by the FDA.
A panel of outside advisers to the FDA are scheduled to meet and review questions about the side effects of Fosamax and other osteoporosis drugs, which may increase the risk…